Get the Stockscreener App
4.70
0.75%
0.0348
Pulmatrix Inc stock is traded at $4.70, with a volume of 3,845.
It is up +0.75% in the last 24 hours and down -4.89% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.6652
Open:
$4.56
24h Volume:
3,845
Relative Volume:
0.37
Market Cap:
$17.17M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-1.9502
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
-0.21%
1M Performance:
-4.89%
6M Performance:
-23.33%
1Y Performance:
-23.08%
1-Day Range:
$4.36
$4.72
1-Week Range:
$4.26
$4.98
52-Week Range:
$4.26
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.70 | 17.04M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Can Pulmatrix Inc. (2PU) stock double in coming yearsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Can Pulmatrix Inc. stock outperform in 2025 bull marketMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Why Pulmatrix Inc. (2PU) stock is a strong analyst pickPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com
What consensus target says about Pulmatrix Inc. (2PU) stockQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Will Pulmatrix Inc. (2PU) stock see valuation expansionInsider Buying & Safe Capital Investment Plans - newser.com
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stockJuly 2025 Review & Reliable Price Breakout Alerts - newser.com
How Pulmatrix Inc. (2PU) stock responds to bond marketQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
How Pulmatrix Inc. stock trades during market volatilityTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Trend analysis for Pulmatrix Inc. this weekPortfolio Gains Report & Technical Confirmation Trade Alerts - newser.com
Will Pulmatrix Inc. stock go up soon2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transitionSell Signal & Real-Time Volume Trigger Notifications - newser.com
Is Pulmatrix Inc. (2PU) stock undervalued by metricsJuly 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
What recovery options are there for Pulmatrix Inc.Treasury Yields & Fast Entry High Yield Stock Tips - newser.com
Is Pulmatrix Inc. stock a smart buy before Fed meetingJuly 2025 Gainers & Pattern Based Trade Signal System - newser.com
What RSI levels show for Pulmatrix Inc. (2PU) stockJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - newser.com
What market sentiment indicators show for Pulmatrix Inc. (2PU) stockMarket Rally & AI Driven Price Predictions - newser.com
Analyzing Pulmatrix Inc. with risk reward ratio chartsWeekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Using RSI to spot recovery in Pulmatrix Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - newser.com
Will breakout in Pulmatrix Inc. lead to full recoveryBull Run & Verified Trade Idea Suggestions - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):